Stocks and Investing
by (remove) : Alethia Young
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Alethia Young
RSSJSONXMLCSV
Thu, June 20, 2024
Tue, September 12, 2023
Thu, September 7, 2023
Mon, August 14, 2023
Fri, August 11, 2023
Tue, August 8, 2023
Mon, July 24, 2023
Thu, July 6, 2023
Fri, October 15, 2021
Fri, July 23, 2021
Fri, June 11, 2021
Mon, March 8, 2021
Wed, February 17, 2021
Wed, February 3, 2021
Thu, October 29, 2020
Wed, October 28, 2020
Mon, October 12, 2020
Tue, August 11, 2020
Fri, July 31, 2020
Wed, July 29, 2020
Fri, May 8, 2020
Wed, May 6, 2020
Mon, May 4, 2020
Fri, May 1, 2020
Mon, April 20, 2020
Wed, April 15, 2020
Wed, March 11, 2020
Fri, March 6, 2020
Tue, March 3, 2020

Alethia Young Reiterated (ARWR) at Buy on, Jun 20th, 2024


Published on 2024-10-28 12:01:36 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Cantor Fitzgerald, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy on, Jun 20th, 2024.

Alethia has made no other calls on ARWR in the last 4 months.



There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


These are the ratings of the 2 analyists that currently disagree with Alethia


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Tuesday, June 11th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Monday, June 3rd, 2024
Contributing Sources